Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
71
ISRG Quote, Financials, Valuation and Earnings
Last price:
$577.14
Seasonality move
:
2.22%
Day range:
$573.30 - $583.45
52-week range:
$425.00 - $616.00
Dividend yield:
0%
P/E ratio:
76.75x
P/S ratio:
21.93x
P/B ratio:
12.14x
Volume:
1.5M
Avg. volume:
1.8M
1-year change:
10.56%
Market cap:
$205.5B
Revenue:
$8.4B
EPS (TTM):
$7.56
Analysts' Opinion
-
Consensus RatingIntuitive Surgical, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 11 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $599.60, Intuitive Surgical, Inc. has an estimated upside of 3.41% from its current price of $579.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $378.00 representing 100% downside risk from its current price of $579.83.
Fair Value
-
According to the consensus of 26 analysts, Intuitive Surgical, Inc. has 3.41% upside to fair value with a price target of $599.60 per share.
ISRG vs. S&P 500
-
Over the past 5 trading days, Intuitive Surgical, Inc. has overperformed the S&P 500 by 1.26% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Intuitive Surgical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Intuitive Surgical, Inc. has grown year-over-year revenues for 20 quarters straight. In the most recent quarter Intuitive Surgical, Inc. reported revenues of $2.5B.
Earnings Growth
-
Intuitive Surgical, Inc. has grown year-over-year earnings for 11 quarters straight. In the most recent quarter Intuitive Surgical, Inc. reported earnings per share of $1.95.
Enterprise value:
200.8B
EV / Invested capital:
11.78x
Price / LTM sales:
21.93x
EV / EBIT:
71.29x
EV / Revenue:
20.89x
PEG ratio (5yr expected):
3.58x
EV / Free cash flow:
88.39x
Price / Operating cash flow:
92.82x
Enterprise value / EBITDA:
59.10x
Gross Profit (TTM):
$6.4B
Return On Assets:
14.51%
Net Income Margin (TTM):
28.77%
Return On Equity:
16.38%
Return On Invested Capital:
16.35%
Operating Margin:
30.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $6.9B | $7.9B | $9.6B | $2B | $2.5B | |
| Gross Profit | $4.6B | $5.3B | $6.4B | $1.4B | $1.7B | |
| Operating Income | $1.7B | $2.1B | $2.8B | $577.3M | $759.7M | |
| EBITDA | $2.1B | $2.5B | $3.4B | $693.5M | $919.7M | |
| Diluted EPS | $4.25 | $6.22 | $7.56 | $1.56 | $1.95 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.7B | $6.3B | $8.9B | $7.2B | $8.5B | |
| Total Assets | $12.9B | $13.3B | $14.7B | $17.7B | $19.4B | |
| Current Liabilities | $1B | $1.2B | $1.7B | $1.7B | $1.8B | |
| Total Liabilities | $1.5B | $1.7B | $2.1B | $2.1B | $2.3B | |
| Total Equity | $11.5B | $11.6B | $12.6B | $15.7B | $17B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2B | $1.8B | $3B | $706.5M | $841M | |
| Cash From Investing | $1.3B | -$3.1B | -$389M | -$1.4B | $401M | |
| Cash From Financing | -$1.2B | $70M | -$2.2B | $98.2M | -$1.8B | |
| Free Cash Flow | $1.3B | $586M | $2.3B | $458.6M | $735.6M | |
ISRG
Sector
Market Cap
$205.5B
$28.4M
Price % of 52-Week High
94.13%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
1.11%
-1.49%
1-Year Price Total Return
10.56%
-16.67%
Beta (5-Year)
1.682
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$559.35
200-day SMA
Buy
Level
$508.36
Bollinger Bands (100)
Buy
Level
448.14 - 552.34
Chaikin Money Flow
Buy
Level
1.1B
20-day SMA
Buy
Level
$564.98
Relative Strength Index (RSI14)
Buy
Level
62.52
ADX Line
Buy
Level
23.46
Williams %R
Sell
Level
-7.9108
50-day SMA
Buy
Level
$541.60
MACD (12, 26)
Buy
Level
5.84
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
1.1B
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (50.0688)
Buy
CA Score
(Annual)
Level (2.0199)
Buy
Beneish M-Score
(Annual)
Level (-2.5144)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-6.1156)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Stock Forecast FAQ
In the current month, ISRG has received 14 Buy ratings 11 Hold ratings, and 1 Sell ratings. The ISRG average analyst price target in the past 3 months is $599.60.
-
Where Will Intuitive Surgical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Intuitive Surgical, Inc. share price will rise to $599.60 per share over the next 12 months.
-
What Do Analysts Say About Intuitive Surgical, Inc.?
Analysts are divided on their view about Intuitive Surgical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Intuitive Surgical, Inc. is a Sell and believe this share price will drop from its current level to $378.00.
-
What Is Intuitive Surgical, Inc.'s Price Target?
The price target for Intuitive Surgical, Inc. over the next 1-year time period is forecast to be $599.60 according to 26 Wall Street analysts, 14 of them rate the stock a Buy, 1 rates the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is ISRG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Intuitive Surgical, Inc. is a Buy. 14 of 26 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ISRG?
You can purchase shares of Intuitive Surgical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Intuitive Surgical, Inc. shares.
-
What Is The Intuitive Surgical, Inc. Share Price Today?
Intuitive Surgical, Inc. was last trading at $577.14 per share. This represents the most recent stock quote for Intuitive Surgical, Inc.. Yesterday, Intuitive Surgical, Inc. closed at $579.83 per share.
-
How To Buy Intuitive Surgical, Inc. Stock Online?
In order to purchase Intuitive Surgical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ISRG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ISRG
Sector
P/E ratio
76.75x
23.89x
PEG ratio
3.58x
-0.01x
P/B ratio
12.14x
1.81x
Price / LTM sales
21.93x
1.58x
Growth Metrics
ISRG
Sector
Revenue growth
22.91%
4.62%
Earnings growth
24.96%
10.7%
Revenue (5-year growth)
13.28%
6.5%
Earnings forecast
$1.99
-$0.21
Profitability
ISRG
Sector
Profitability FY 2024
$5.6B
$3.6M
Return on invested capital
16.35%
-31.84%
Return on assets
14.51%
-27.96%
Return on equity
16.38%
-37.63%
Earnings Date
Last Earnings Date
Oct
21
Next Earnings Date
Jan
22
Estimated Next Earnings Date
Jan
20
Balance Sheet
ISRG
Sector
Total cash
$4.9B
$26.4M
Short term investments
$2B
$25.7M
Total assets
$18.8B
$76.9M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is down 0.27% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
